AIDS-related disorder

Summary

AIDS-related disorder (MONDO:0024571) is a disease and 2 clinical trials. A subtype of post-viral disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	AIDS-related disorder
Mondo ID	MONDO:0024571
EFO	EFO:0009528
NCIT	C4991
UMLS	C0877121
MedGen	852920
Is cancer (heuristic)	no

Also known as: AIDS-related complications · AIDS-related disorder · AIDS/HIV - relatedDisease associated with AIDS · disease associated with AIDS

Disease family

This is a subtype of post-viral disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › post-infectious disorder › post-viral disorder › AIDS-related disorder

Related subtypes (12): oral hairy leukoplakia, Zika virus congenital syndrome, viral dilated cardiomyopathy, hepatitis C induced liver cirrhosis, herpes zoster, hepatitis D virus infection, immunodeficiency 32B, virus associated tumor, rubella encephalitis, AIDS dementia complex, post-infectious neuralgia, post-COVID-19 disorder

Subtypes (4): HIV enteropathy, HIV wasting syndrome, HIV-associated nephropathy, HIV-associated cancer

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
EARLY_PHASE1	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06541093	EARLY_PHASE1	COMPLETED	Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.
NCT04033120	Not specified	COMPLETED	Making an Early Diagnosis of Talaromycosis Using a Novel Antigen Test